Method of preparing 1,3-butadiene and methyl ethyl ketone from 2,3-butanediol using adiabatic reactor
US-2017342009-A1 · Nov 30, 2017 · US
US10138192B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10138192-B2 |
| Application number | US-201615559817-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 17, 2016 |
| Priority date | Mar 20, 2015 |
| Publication date | Nov 27, 2018 |
| Grant date | Nov 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
One-step cyanide-catalyzed benzoin condensations for synthesizing shape persistent cyclobenzoin macrocycles. Selected dialdehydes, and cyanide salts are reacted in aqueous solvents to form such cyclobenzoin macrocycles.
Opening claim text (preview).
What is claimed is: 1. A one-step method of synthesizing a cyclobenzoin macrocycle, comprising: reacting a dialdehyde (A) in a concentration of between 0.1M to 1M, and a cyanide salt catalyst in an aqueous solvent wherein said solvent is in a 1:1 molar ratio with H 2 O to form a cyclobenzoin (B) macrocycle, wherein n is selected from group comprising 1, 2, or 3; and M is 3, or 4, and wherein said reacting the dialdehyde and the cyanide salt catalyst comprises refluxing at a temperature of about 100° C. 2. The method of claim 1 , wherein said solvent is an alcohol. 3. The method of claim 2 , wherein said alcohol is selected from the group consisting of 2-methoxyethanol; ethanol; methanol; propanol, butanol, pentanol isomers, and glycols. 4. The method of claim 1 , wherein said dialdehyde is selected from the group consisting of isophthaldehyde; tetraphthaldehyde; phthaldehyde, and aromatic analogs thereof, wherein one or more substituted or unsubstituted aromatic or hetoroaromatic rings, and/or triple bonds are inserted between two formyl groups. 5. The method of claim 4 , wherein said dialdehyde is isophthaldehyde in a concentration of about 0.5M. 6. The method of claim 4 , wherein said dialdehyde is tetraphthaldehyde in a concentration of about 0.17M. 7. The method of claim 1 , wherein said reacting a dialdehyde and a cyanide salt comprises refluxing under nitrogen gas at a temperature of about 100° C. for about 48 hrs. 8. The method of claim 1 , wherein said cyanide salt is selected from the group consisting of NaCN, cyanide salts of metals; and thiazolium salts. 9. The method of claim 5 , wherein said cyclobenzoin macrocycle is cyclotribenzoin or a cyclotetrabenzoin. 10. The method of claim 1 , wherein said cyclobenzoin macrocycle forms a microporous three-dimensional organic framework, or a one dimensional nanotube channel. 11. The method of claim 1 , wherein said cyclobenzoin macrocycle is porous. 12. The method of claim 1 , wherein said cyclotetrabenzoin comprises a Langmuir surface area of about 52 m 2 g −1 . 13. The method of claim 1 , wherein said cyclobenzoin macrocycles further comprise porous materials, assemblies at liquid-solid interfaces, or organic nanowires and nanofibrils. 14. The method of claim 1 , wherein said cyclobenzoin comprises a synthetic receptor macromolecule. 15. A cyclotetrabenzoin macrocycle; comprising: a square shape-persistent 3-dimensional structure, wherein said square shape-persistent 3-dimensional structure comprises four outer polar α-hydroxyketone moieties; and a central nonpolar cavity, or a cone shape-persistent 3-dimensional structure, wherein said cone shape-persistent 3-dimensional structure comprises convergent anionic and cationic binding groups . 16. The cyclotetrabenzoin macrocycle of claim 15 , wherein said macrocycle is intrinsically porous, and comprises a 10% void volume. 17. The cyclotetrabenzoin macrocycle of claim 15 , wherein said central non-polar cavity comprises an area of about 6.9×6.9Å. 18. The cyclotetrabenzoin macrocycle of claim 15 , wherein said α-hydroxyketone moieties comprise hydrogen bonds to further units of cyclotetrabenzoin to form hydrogen-bonded nanotubular subunits. 19. The cyclotetrabenzoin macrocycle of claim 15 , wherein said α-hydroxyketone moieties comprise hydrogen bonds to molecular guest molecules. 20. The cyclotetrabenzoin macrocycle of claim 15 , wherein said α-hydroxyketone moieties, cationic binding groups, or anioic binding groups are selectively derivatized. 21. The cyclotribenzoin macrocycle of claim 20 , wherein said anionic and cationic binding groups bond with guest molecules.
polycyclic non-condensed · CPC title
Diformyl benzenes; Alkylated derivatives thereof · CPC title
polycyclic · CPC title
with a five-membered ring · CPC title
a keto group being part of a condensed ring system · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.